Cicor Technologies Ltd (CICN)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 23 Oct 2026
Key indicators
| Last close | CHF 127.60 |
|---|---|
| 52-week range | 110.20 – 229.00 |
| Return, 1 month / 3 months | −8.9% / +4.1% |
| Return, 1 year / 3 years | −33.9% / +192.7% |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 63.8% |
| Worst drawdown (1 year) | -49.8% |
| Average daily value traded | 1.71M CHF |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cicor Technologies is a Swiss industrial group that makes printed circuit boards, hybrid circuits and electronic assemblies, and provides related manufacturing services. Its customers are mainly original equipment manufacturers in fields such as medical technology, industrial electronics, aerospace and defence, who rely on Cicor for circuit boards and complete electronic modules. The company is based in Switzerland and operates production sites in several European countries and other regions, supplying both local and international markets.
Cicor Technologies Ltd trades under the code CICN on the SIX Swiss Exchange in Switzerland, with its price quoted in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cicor Technologies Ltd (CICN) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 127.60 on 23 October 2026.
Its price-based Market X-Ray is 30 out of 100 (a weak price profile), ranking 189 of 226 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 33.9% and over the last three months it rose 4.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 30 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -3.5% | ||
| From 52-week high | -42.3% | ||
| Momentum | 35 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 4.1% | ||
| 6-month return | -4.2% | ||
| 12-month return, skipping the last month | -27.5% | ||
| Stability (higher is calmer) | 9 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 63.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -49.8% | ||
| Liquidity | 53 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.71M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −4.6% |
|---|---|
| 1 month | −8.9% |
| 3 months | +4.1% |
| 6 months | −4.2% |
| 1 year | −33.9% |
| 3 years | +192.7% |
| 5 years | +127.9% |
Signals
| 50-day / 200-day average | 131.92 / 132.23 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.99 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Apr 2021 | CHF 1.0000 |
| 21 Apr 2020 | CHF 1.5000 |
| 23 Apr 2019 | CHF 1.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.